AI assistant
Butterfly Network, Inc. — Director's Dealing 2021
Feb 17, 2021
32836_dirs_2021-02-16_ee8b29dd-6af9-46d1-994d-935a20007a7d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Butterfly Network, Inc. (BFLY)
CIK: 0001804176
Period of Report: 2021-02-12
Reporting Person: Fruchterman Todd (Director, President and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-12 | Class A Common Stock | A | 1038300 | — | Acquired | 1038300 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-12 | Stock Option (right to buy) | $15.29 | A | 1557450 | Acquired | 2031-01-23 | Class A Common Stock (1557450) | Direct |
Footnotes
F1: Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest in 4 equal annual installments on the anniversary of the start of Dr. Fruchterman's employment by Butterfly (defined below), February 1, 2021, subject to his continued service through the applicable vesting date.
F2: In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of November 19, 2020, by and among Longview Acquisition
Corp. ("Longview"), Clay Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Longview ("Merger Sub"), and Butterfly Network, Inc., a Delaware
corporation ("Butterfly"), pursuant to which Merger Sub merged with and into Butterfly (the "Merger"), with Butterfly surviving as a wholly-owned subsidiary of Longview
(which changed its name to "Butterfly Network, Inc.", the "Issuer"), these RSUs were received in exchange for 1,000,000 RSUs of Butterfly.
F3: The shares underlying this option vest as to 25% on February 1, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to Dr. Fruchterman's continued service through the applicable vesting date.
F4: Received in connection with the Merger in exchange for a stock option to acquire 1,500,000 shares of Butterfly common stock for $15.87 per share.